Healthcare - Events

This April, the 3rd LNP Formulation and Process Development Summit returns to Boston, bringing together over 400 experts in LNP Biology, Chemistry, Formulation, Analytical Development, Process Development, Manufacturing and more. This is your ultimate platform for sharing insights, learning new concepts and networking to propel more LNPs into the clinic in 2024. Join the ever-growing community of LNP pioneers as they tackle the challenges associated with developing safe, compliant and efficacious LNPs, to treat a variety of disease indications at a variety of target organs. This starts with the in vitro discovery of LNPs through to the manufacturing processes, with end-to-end synergy fundamental.Hear from industry powerhouses Pfizer, Moderna, Alnylam and more, as well as new companies to s…

The Summit is designed to present and discuss what we know and do not know about how vascular disease presents differently in women, and how an intervention is impacted by gender. Featuring an international faculty, interactive group discussions and projects, mentorship program for vascular trainees, and an evening reception. After the flagship meeting in 2019, multiple research projects have been undertaken assessing differences in outcomes based on gender. The meeting also serves to connect women Vascular Surgeons and other practitioners involved in vascular disease from students to senior surgeons. What is this meeting about?Topics include the broad spectrum of vascular disorders including peripheral arterial disease, cerebrovascular disease, aortic aneurysms, aortic dissections, access…

This conference will be continuing with debates as well as adhering to the format of the previous conferences which are designed to provide an in-depth progress report on new antiepileptic drugs in various stages of development, as well as to present new findings on second-generation treatments. All persons related to the field are invited to attend.

The development of mono- and bivalent degraders continues to gain traction, but biopharma faces challenges in rapidly discovering, validating, and utilizing novel E3 ligases. This leaves therapeutic opportunities untapped due to obstacles in ligase screening, structural characterization, and assaying therapeutic efficacy. The Annual Ligase Targeting Drug Development Summit, now in its 4th year, will unite 80+ ligase experts dedicated to tackling ligase bottlenecks through data-driven presentations, technical discussions, and interactive sessions, unlocking the potential of E3 ligases for novel drug targets.

Pioneering the Next Breakthrough in Durable and Potent RNA Therapeutics for Patients The field of next generation RNA therapeutics continues to progress towards clinical translation, with enormous investments and collaborations, such as Orbital Therapeutics’ recent $270 million Series A financing. The 3rd Next Generation RNA Therapeutics Summit returns to cover the depth and breadth of the next of generation RNAs, including circular RNA, self-amplifying RNA (saRNA) and beyond from discovery to clinic and towards scalable manufacturing, unlocking the huge therapeutic and commercial potential of this emerging class of modalities. Join 120+ expert leaders in Discovery, R AND D, Engineering, Preclinical Translation and CMC from the key stakeholders pioneering advances in RNA technologies and c…

Injectable Drug Delivery is an industry focused on two overarching topics the development of the device and the interaction between drug product and device. SAE’s 2024 Injectable Drug Delivery conference brings together a complete big pharma speaker line-up providing technical updates on the relationship between drug product formulation and the device primary packaging, with considerations for formulation strategies, extractables and leachables and toxicological testing of injectable devices. This conference brings case studies from senior big pharma representatives providing an opportunity to discuss formulation considerations in depth for parenteral packaging, this is the perfect opportunity to benchmark your drug delivery programme and optimise the development of your injectable portfol…

Welcome to the Digital Health Envision Summit, where the future of healthcare comes to life! Join us as we bring together Dealmakers, Innovators, Investors, and Decision-makers from the Pharma & Biotech sector to explore the transformative potential of Digital Health therapies and technologies. This Summit is the ultimate platform for discovering new products, unlocking business opportunities, fostering collaboration, and igniting innovation in the industry Immerse yourself in a dynamic environment where Big, Midsize, and Small Pharma & Biotech companies come together to showcase their cutting-edge assets, revolutionary products, ground-breaking technologies, innovative platforms, and game-changing services. Connect with potential Partners and visionary minds who share your passion…

The Pharma Partnering Summit is an exclusive Life Sciences Industry event, with the aim to help companies expand their network and put together licensing deals, research collaborations and financing. Our platform brings together senior executives from different parts of the world specialising in Business Development & Licensing, Alliance Management, Research Collaborations, M&A and Investment. In addition to identifying products and partners as well as investors, the forum also serves to disseminate knowledge through expert speakers, for the best practices in the field of industry partnerships.   Registration Link: https://pharma-partnering-summit.com/registration.html

Strengthening supplier and internal stakeholder collaborations, innovating in- and outsourcing models, and adopting advanced technologies to streamline development cycle are key to achieving speed-to-patients and capital efficiency – and this is what the 8th R AND D Procurement and Sourcing in Pharma Summit will bring to the table in 2024. Growing with this community over the last 8 years, the summit remains the definitive community for 100+ R AND D Preclinical, Clinical Procurement, Sourcing, Category Management leaders from the likes of Takeda, Eli Lilly, Sarepta, Moderna, Jazz Pharmaceuticals, and Gilead to benchmark best practice, network and seek inspirations. Unlock the benefits of our 3-day summit with dedicated preclinical and clinical tracks. Gain insights from 20+ real-life stori…

Wednesday, May 15, 2024 | 3:00 – 4:00 PM CET  Convincing trial physicians to participate in a clinical trial is an ongoing challenge for sponsors and CROs. For physicians, trials are burdensome on many levels including the time required, administrative hurdles and communications with sponsors and patients. Often, there is little academic merit waiting for them at the end. So it’s not surprising that physicians prefer to put their efforts elsewhere.  Yet, without trials, there is little scientific advancement and less chance to help patients with novel treatments. In this webinar, we are joined by former physician and former CSO of Novartis, Professor Lothar Färber to present exclusive findings from a recent survey conducted by Climedo and Siteworks among 65+ European tr…

Scientex Conferences warmly welcomes all the Participants, Scientists, Doctors, Nurses and Delegates from the globe to join our conference "2nd International Conference on Nursing Care and Patient Safety” on May 16-17, 2024 in Bangkok, Thailand. Nursing Care 2024 is organized around the theme "Analyzing the latest technologies and research in nursing care and patient safety " which will mark a gathering of pioneers and experts from the Medical Industry.

Prioritizing Back Translation from Bedside to Bench and Novel TargetsWith a whopping 7 approvals in the last two years, the field is alive with positive clinical read outs and the drive to get more life changing cell engager therapeutics to patients in indications of huge unmet need. The timely 6th Cell Engager Therapeutics Summit is back once again to meet the needs of the community, focused on reaching new indications by expanding the target space and focusing our content to novel targets as well as continuing the push to focus on the translational challenges of developing cell engager therapies for solid and liquid tumors. Join 100+ of your colleagues from JNJ, Astellas, Amgen, CDR-Life, Regeneron, Immunocore, Crossbow Therapeutics and AstraZeneca in discovery and translational sciences…

Identify Transformative ALS Targets, Seek Translational Biomarkers and Propel More Clinical Approvals Following monumental progress in 2023, the ALS treatment landscape is surging with novel innovation to navigate the complex, multifactorial nature of motor neuron degeneration and develop more truly transformative drugs for sporadic and familial ALS. Capitalizing on rapid pipeline progress and emerging industry investment, the 3rd Annual ALS Drug Development Summit returns to Boston, providing a comprehensive breakdown of the latest motor neuron models, biomarker strategies, approval insights, and novel approaches to target the likes of TDP-43, STMN2, and PIKfyve. Engage in forward-thinking discussions and gain fresh perspectives on the most meaningful endpoints and trial design considerat…

Join this interactive event of like-minded quality-first clinical professionals to explore effective strategies to ensure clinical risk is being mitigated and managed across all stakeholders. Date and Time: Tuesday, 21 May 2024 at 09:00 to Thursday, 23 May 2024 at 17:00

The FDA Modernization Act 2.0 has triggered a new mindset for pharma, with Roche launching the Institute of Human Biology to create better models, and MSD collaborating with Inventia to bioprint 3D in vitro models to screen for neurodegenerative therapeutic candidates. It has never been a more exciting time to bet on 3D tissue models as the future of drug development, as more and more complex in vitro models undergo validation. However, the big question of "when can we have the confidence in standalone 3D models, and how to do it at scale?" persists. Making its timely return to Boston this May, the 9th 3D Tissue Models Summit will enable you and your team to uncover best practices across 23+ real-world applications of complex in vitro models across drug discovery and development. Join us t…

While leading cytokine therapeutic developers are using next-generation cytokine engineering technologies to tackle enduring efficacy and toxicity challenges to take their molecules through the clinic, the field is also looking to novel targets, novel cytokines and an expanded disease focus. As we enter a new era for cytokine therapies, armed with more cutting-edge technologies than ever before and enhanced translational understandings, the field is re-energizing the cytokine space to bring more life-changing drugs to patients. Curating learnings from previous experiences, the 5th Cytokine-Based Drug Development Summit returns as the only industry dedicated cytokine meeting with a disease agnostic approach. The packed 3-day agenda will be addressing topics ranging from oncology to autoimmu…

The Pharma Partnering Summit is an exclusive Life Sciences Industry event, with the aim to help companies expand their network and put together licensing deals, research collaborations and financing. Our platform brings together senior executives from different parts of the world specialising in Business Development & Licensing, Alliance Management, Research Collaborations, M&A and Investment. In addition to identifying products and partners as well as investors, the forum also serves to disseminate knowledge through expert speakers, for the best practices in the field of industry partnerships.  Rehistration Link:  https://pharma-partnering-summit.com/registration.html

Following the success of the 3rd Annual Psychedelic Therapeutics and Drug Development Conference in 2023, we're thrilled to be hosting the 4th Annual event on May 23-24, 2024 in Boston, Massachusetts. This event has been organized to bring together the world's leading researchers and leaders in academia, industry, the non-profit sector and government to discuss the challenges and opportunities facing those engaged in the research and development of psychedelics for various health conditions with considerable unmet need. This event will highlight the progress being made towards regulatory approval of a variety of psychedelics with the potential to treat various conditions, including inflammatory/autoimmune disorders, brain injury, pain, PTSD, anxiety, ADHD, headaches, depression, and opioid…

As in previous meetings, the 12th FemDIP Symposium will highlight the progress of pregnancy: from pre-pregnancy, trimester by trimester, to labor, delivery and post-partum care, but also will create a Bridge Connecting Medical/Scientific and FemTech Communities. The Symposium's Startup Pavilion will provide an opportunity for startups to connect with key figures in the industry. Date and Time: On Thu, 23 May 2024 14:00 - Sat, 25 May 2024 19:00